Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
Find the perfect cards to make your season’s greetings go even further. Every pack purchased will help fund vital research and support for people living with type 1 diabetes.
Researchers need your help. By taking part in research studies and clinical trials, you will help them make progress to improve lives and find a cure for type 1 diabetes.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Your donation helps support people living with type 1 diabetes and funds the best treatment and cure research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > News & Events > Sign up for our newsletter
Subscribe to receive Breakthrough T1D’s e-newsletters and you’ll be the first to know about all of this and more.
We promise to keep your details secure and we won’t share your information with any other organisations. If you decide you’d rather not hear from us then you can unsubscribe at any time.
To sign up, simply complete your details below and press submit.
We respect your privacy. We will never share your information with any third party. For full details see our privacy policy.
A US clinical trial is exploring whether tegoprubart could make islet transplants an option for people with type 1 diabetes (T1D) and kidney disease, with funding from Breakthrough T1D.
The inaugural Breakthrough T1D Clinical & Research Congress (CRC) brought together more than 1,000 clinicians, researchers, industry leaders and members of the type 1 diabetes (T1D) community from around the world.
The European Association for the Study of Diabetes (EASD) is the continent's largest diabetes conference. It brought together researchers from around the world to share the latest developments in type 1 diabetes (T1D) research.
A new international position statement says people with diabetes should often be able to keep using continuous glucose monitors, insulin pumps and hybrid closed loop systems during a hospital stay, as long as it is safe and appropriate.
New Breakthrough T1D-funded research from Harvard, USA, has found a link between how gut bacteria develops in early childhood and the risk of type 1 diabetes (T1D).
Researchers from John Hopkins University, USA, partially funded by Breakthrough T1D, have developed an experimental treatment that protects the insulin-producing cells from inflammatory damage, allowing them to survive for longer in animal models.
We are delighted with the decision to approve teplizumab for use on the NHS.
We look at a new feature coming to the CamAPS FX app, which will allow users to remove the need to count carbohydrates before a meal.
Would you like to visit the website of our {{ affiliate_country }} affiliate to complete your action?